Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 4:2
Drug Approvals
113
NMPA:68
EMC:42
SFDA:3
Drug Approvals
Morphine Sulphate Sustained-release Tablets
- Product Name
- 硫酸吗啡缓释片
- Approval Number
- 国药准字HJ20130904
- Approval Date
- Aug 6, 2024
NMPA
Morphine Sulphate Sustained-release Tablets
- Product Name
- 硫酸吗啡缓释片
- Approval Number
- 国药准字HJ20130903
- Approval Date
- Aug 6, 2024
NMPA
Morphine Sulphate Sustained-release Tablets
- Product Name
- 硫酸吗啡缓释片
- Approval Number
- 国药准字HJ20130901
- Approval Date
- Jun 14, 2024
NMPA
Morphine Sulphate Sustained-release Tablets
- Product Name
- 硫酸吗啡缓释片
- Approval Number
- 国药准字HJ20130900
- Approval Date
- Jun 14, 2024
NMPA
Oxycodone Hydrochloride Prolonged-release Tablets
- Product Name
- 奥施康定
- Approval Number
- 国药准字HJ20140324
- Approval Date
- Feb 6, 2024
NMPA
Oxycodone Hydrochloride Prolonged-release Tablets
- Product Name
- 奥施康定
- Approval Number
- 国药准字HJ20170052
- Approval Date
- Feb 6, 2024
NMPA
Oxycodone Hydrochloride Prolonged-release Tablets
- Product Name
- 奥施康定
- Approval Number
- 国药准字HJ20140314
- Approval Date
- Feb 6, 2024
NMPA
Oxycodone Hydrochloride Prolonged-release Tablets
- Product Name
- 奥施康定
- Approval Number
- 国药准字HJ20140320
- Approval Date
- Feb 6, 2024
NMPA
Oxycodone Hydrochloride Prolonged-release Tablets
- Product Name
- 奥施康定
- Approval Number
- 国药准字HJ20140312
- Approval Date
- Feb 6, 2024
NMPA
Oxycodone Hydrochloride Prolonged-release Tablets
- Product Name
- 奥施康定
- Approval Number
- 国药准字HJ20140313
- Approval Date
- Feb 6, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (100.0%)A Study to Compare Oxycodone/Naloxone Prolonged Release Against Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis
Phase 4
Completed
- Conditions
- OsteoarthritisBack Pain
- Interventions
- Drug: Oxycodone/NaloxoneDrug: Codeine/Paracetamol
- First Posted Date
- 2008-11-04
- Last Posted Date
- 2011-11-02
- Lead Sponsor
- Napp Pharmaceuticals Limited
- Target Recruit Count
- 247
- Registration Number
- NCT00784810
Buprenorphine in the Treatment of Osteoarthritis (OA) in the Elderly
- First Posted Date
- 2006-05-10
- Last Posted Date
- 2011-06-14
- Lead Sponsor
- Napp Pharmaceuticals Limited
- Target Recruit Count
- 219
- Registration Number
- NCT00324038
- Locations
- 🇬🇧
Napp Pharmaceuticals Ltd, Cambridge, United Kingdom
News
No news found